Atlas Trials

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

Clinical trial NCT01356160 · COMPLETED

Trial details

NCT number
NCT01356160
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2011-07-01
Primary completion
2013-06-01
Enrollment
351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.